Colavolpe, C., Chinot, O., Metellus, P., Mancini, J., Barrie, M., Bequet-Boucard, C., . . . Guedj, E. (2012). FDG-PET predicts survival in recurrent high-grade gliomas treated with bevacizumab and irinotecan. Oxford University Press.
Dyfyniad Arddull ChicagoColavolpe, Cécile, et al. FDG-PET Predicts Survival in Recurrent High-grade Gliomas Treated With Bevacizumab and Irinotecan. Oxford University Press, 2012.
Dyfyniad MLAColavolpe, Cécile, et al. FDG-PET Predicts Survival in Recurrent High-grade Gliomas Treated With Bevacizumab and Irinotecan. Oxford University Press, 2012.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.